Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2009.248 | A randomized phase II study comparing acupuncture to acupuncture with moxibustion on reduction of chemotherapy-induced neutropenia | Professor Mok Tony |
| 2008.479 | A Randomized Phase I/II, Multi-Center, Open-Label Trial of PR104 and Sorafenib in Patients with Advanced Hepatocellular Carcinoma | Dr. Chan Stephen Lam |
| 2010.602 | A Randomized Phase 4 Study Comparing 2 Intravenous Temsirolimus (TEMSR) Regimens in Subjects With Relapsed, Refractory Mantle Cell Lymphoma | Dr. LEI Kenny Ieng Kit |
| 2021.631 | A Randomized Phase 3 Study of MRTX849 versus Docetaxel in Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation |
Prof. MOK Tony Shu Kam 莫樹錦 |
| 2022.654 | A Randomized Phase 3 Study of Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab, with or Without Platinum Chemotherapy, in Subjects with No Prior Therapy for Advanced or Metastatic PD-L1 TPS <50% Non-squamous Non-small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-Lung07) | Dr. LOONG Herbert Ho Fung |
| 2011.179 | A Randomized Phase 3 Study Comparing First-Line Pemetrexed plus Cisplatin (Followed by Gefitinib as Maintenance) with Gefitinib Monotherapy in East Asian (Never Smoker or Light Ex-Smoker) Patients with Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer | Prof. Mok Tony Shu Kam |
| 2020.025 | A Randomized Phase 3 Multicenter Open-label Study to Compare the Efficacy of TAK-788 as First-line Treatment Versus Platinum-Based Chemotherapy in Patients With Non–Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations |
Prof. MOK Tony 莫樹錦教授 |
| 2009.024 | A Randomized Phase 2 Trial of PF-00299804 versus Erlotinib for the Treatment of Advanced Non-Small Cell Lung Cancer after Failure of at Least One Prior Chemotherapy Regimen | Prof. Mok TONY S.K. |
| 2007.471 | A Randomized Phase 2 Trial of Double-Blind, Placebo Controlled AMG 706 in Combination with Paclitaxel, or Open-Label Bevacizumab in Combination with Paclitaxel, as First Line Therapy in Women with HER2 Negative Locally Recurrent or Metastatic Breast Cancer | Dr. HO Wing Ming |
| 2014.404 | A Randomized Phase 2 Study of LY2157299 versus LY2157299 – Sorafenib Combination versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma | Prof. CHAN Stephen Lam |
| 2025.306 | A Randomized Phase 2 Study of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma | Prof. CHAN Stephen Lam |
| 2008.229 | A Randomized Phase 2 Study Comparing Erlotinib-Pemetrexed, Pemetrexed Alone, and Erlotinib Alone, As Second-Line Treatment for Non-Smoker Patients with Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer | Professor Mok Tony S. K. |
| 2016.506 | A Randomized Parallel-Group, Placebo-Controlled, Double-Blind, Event-Driven, Multi-Center Pivotal Phase III Clinical Outcome Trial of Efficacy and Safety of the Oral sGC Stimulator Vericiguat in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF) - VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) |
Prof. LEE Alex Pui Wai 李沛威教授 |
| 2012.279 | A randomized parallel group single blinded study of effects of Dayan (Wild Goose) Qigong on type 2 diabetes patients with low cardiovascular risk. | Dr. Tsang Chiu-Chi |
| 2016.551 | A Randomized Open-label Study to Evaluate the Efficacy and Safety of Tacrolimus and Corticosteroids in Comparison with Mycophenolate Mofetil and Corticosteroids in Subjects with Class III/IV±V Lupus Nephritis |
Prof. TAM Lai Shan 譚麗珊 |
| 2015.507 | A Randomized Open-Label Phase III Study of Single Agent Pembrolizumab versus Single Agent Chemotherapy per Physician’s Choice for Metastatic Triple Negative Breast Cancer (mTNBC) – (KEYNOTE-119) |
Prof. YEO Winnie 楊明明 |
| 2021.640 | A Randomized Open-Label Phase III Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Subjects with Metastatic or Locally Advanced Unresectable Urothelial Cancer |
Dr. WONG Kenneth Chun Wai 王俊威 |
| 2023.583 | A Randomized Open-Label Phase 3 Study of XL092 + Nivolumab vs Sunitinib in Subjects with Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma | Prof. NG Chi Fai |
| 2022.413 | A Randomized Open-Label Phase 3 Study of XL092 + Atezolizumab vs Regorafenib in Subjects with Metastatic Colorectal Cancer |
Prof. MA Brigette Buig Yue 馬碧如 |
| 2021.497 | A Randomized Multicenter Phase 3 Study of Milademetan Versus Trabectedin in Patients with Dedifferentiated Liposarcoma |
Dr. LOONG Herbert Ho Fung 龍浩鋒 |
| 2011.339 | A randomized double-blinded, controlled evaluation of the effectiveness of iv PCA morphine in patients receiving intercostal nerve blocks after video-assisted thoracosopic procedure. Is PCA morphine necessary in addition to intercostals nerve block for Vi | Dr Lam Kit Ying |
| 2020.080 | A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein (a) lowering with TQJ230 on major cardiovascular events in patients with established cardiovascular disease |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2004.035 | A Randomized Double-Blind Placebo-Controlled Trial of Prophylactic Antibiotics in Preventing Female Urinary Tract Infection After Urodynamic Study | Prof. Yip Shing Kai |
| 2004.134 | A Randomized Double-blind Placebo-controlled Study to Assess the Prevention of Low-dose Acetylsalicylic Acid (ASA) Associated Gastroduodenal Lesions and Upper Gastrointestinal Symptoms in Patients Taking Esomeprazole 20 mg Once Daily (od) for 26 Weeks | Prof. Chan Ka Leung Francis |
| 2002.152 | A Randomized Double-Blind Placebo-Controlled Study of The Effect Of Danggui Preparation On Menopausal Symptoms And Quality Of Life In Hong Kong Chinese Women | Prof. Haines Christopher John |
| 2005.418 | A Randomized Double-Blind Phase-2 Study of Anastrozole Plus Lonafarnib (SCH 66336) or Anastrozole Plus Placebo for the Treatment of Subjects With Advanced Breast Cancer | Prof. Yeo Winnie |
| 2004.126 | A Randomized Double-blind Dose-dependent Trial to Assess the Safety and Efficacy of HERBAL FORMULA on Patients with Lung Cancer | Prof. Liew Choong Tsek |
| 2004.127 | A Randomized Double-blind Dose-dependent Trial to Assess the Safety and Efficacy of HERBAL FORMULA on Patients with Colorectal Cancer | Prof. Liew Choong Tsek |
| 2011.396 | A Randomized Double Blind Phase 3 Efficacy And Safety Study Of PF-00299804 Versus Erlotinib For The Treatment Of Advanced Non-Small Cell Lung Cancer Following Progression After, Or Intolerance To, At Least One Prior Chemotherapy | Prof. MOK Tony |
| 2016.725 | A randomized crossover trial to investigate the effects of walnut intervention on blood lipids, inflammatory markers, blood pressure, and adiposity measurements among breast cancer survivors in Hong Kong |
Prof. Su Xuefen 蘇雪芬 |
| 2012.530 | A randomized crossover trial to compare the changes of postprandial oxidative stress after consumption of meals from different cultures in healthy Chinese adults | Prof Chan Suk-mei Ruth |
| 2017.541 | A randomized controlled, single blinded study on the efficacy of a hybrid tilt table and electromechanical gait-training device in lower limb recovery in patients with severe stroke |
Dr. FAN Florence Sin Ying 樊倩英 |
| 2009.535 | A randomized controlled trial: the effect of a targeted secondary prevention program on quality of life and risk factor control in Chinese patients with acute coronary syndrome | Associate Professor Lam Yat Yin |
| 2001.488 | A Randomized Controlled Trial to Investigate the Role of Indocyanine Green-Assited Retinal Limiting Membrane Removal in Primary Idiopathic Macular Hole Surgery | Prof. Kwok Kwan Ho Alvin |
| 2013.094 | A randomized controlled trial to investigate the independent and joint effects of diet and exercise on endogenous estrogen concentrations among overweight/obese postmenopausal Chinese women in Hong Kong | Prof. Su Xuefen |
| 2010.516 | A randomized controlled trial to investigate the impact of sleep education program on glycemic control in Hong Kong Chinese type 2 diabetic patients. | Prof. KONG Alice Pik Shan |
| 2015.358 | A Randomized Controlled Trial to Investigate the Impact of a self-managed Low Glycemic Index Diet program (SLGID) on Outcomes of Metabolic Syndrome Patients |
Prof. CHAIR Sek Ying 車錫英 |
| 2009.088 | A Randomized Controlled Trial to Investigate the Impact of a Low Glycemic Index (GI) Diet on Body Mass Index and Obesity Related Cardiovascular and Hormonal Factors in Chinese Adolescents | Prof Kong Alice Pik Shan |
| 2019.332 | A randomized controlled trial to investigate the associations between a music program and neonatal health outcomes |
Ms. CHENG Shuk Man 鄭淑雯 |
| 2017.015 | A randomized controlled trial to examine the effectiveness of a genotype based lifestyle modification program on weight reduction in Chinese overweight and obese adults |
Dr. CHAN Ruth Suk Mei 陳淑薇 |
| 2003.127 | A Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions | Prof. Chan W.M. Wilson |
| 2019.663 | A randomized controlled trial to evaluate the efficacy of intervention involving motivational interviewing and implementation intentions to motivate working mothers to continue exclusive breastfeeding | Dr. LAU Yin Kei |
| 2017.139 | A randomized controlled trial to evaluate the effectiveness of an ehealth antenatal exercise intervention in improving lumbopelvic pain in Hong Kong Chinese pregnant women |
Mrs. AU YEUNG Elce 歐陽凱詩 |
| 2003.189 | A Randomized Controlled Trial to Evaluate the Credibility of a Sham Acupuncture Design | Prof. Tang Jin Ling |
| 2021.408 | A randomized controlled trial to evaluate efficacy of a brief online integrated self-affirmation and implementation intention intervention in improving medication adherence among uncontrolled hypertensive patients | Prof. MO Phoenix Kit Han |
| 2004.071 | A Randomized Controlled Trial to Compare the Safety and Efficacy of Intravitreal Triamcinolone Versus Macular Laser Photocoagulation in the Treatment o f Clinically Significant Diabetic Macular Edema | Prof. Chan K.M. Carmen |
| 2002.403 | A Randomized Controlled Trial to Compare the Safety and Efficacy of Intravitreal Triamcinolone Versus Grid Laser In Treatment of Clinically Significant Diabetic Macular Edema(CSME) | Prof. Lam Shun Chiu Dennis |
| 2004.444 | A Randomized Controlled Trial to Compare the Safety and Efficacy of Intravitreal Triamcinolone Versus Combined Triamcinolone and Grid Laser Versus Observation in the Treatment of Macular Edema Associated With Central Retina Vein Occlusion | Prof. Lam S.C. Dennis |
| 2005.249 | A Randomized Controlled Trial to Compare the Safety and Efficacy of Grid Laser Versus Posterior Subtenon Triamcinolone Versus Combined Subtenon Triamcinolone and Grid Laser in the Treatment of Clinically Significant Diabetic Macular Edema | Prof. Lam S.C. Dennis |
| 2009.042 | A Randomized Controlled Trial to Compare the Efficacy and Safety of 1) Macular Laser vs. 2) Repeated Intravitreal Bevacizumab vs. 3) Combined Repeated Intravitreal Bevacizumab with Macular Laser for Diabetic Macular Edema | Prof. Lam Shun Chiu Dennis |
Page 229 of 265.